Department of Medicine
Faculty Profiles by Division

Department of Medicine

Faculty Profiles

[Return To Index page]
photo Jane M. Liebschutz, MD, MPH, FACP

General Internal Medicine

Chief, Division of General Internal Medicine

Professor of Medicine with Tenure

Falk Professor in Ambulatory Care

UPMC Endowed Chair of Translational Medicine and Research

Director, Center for Research on Health Care

Email: liebschutzjm@upmc.edu

Phone: 412-692-4821

Contact
Office: UPMC Montefiore Hospital, Suite 933W
200 Lothrop Street
Pittsburgh, PA 15213
 
Phone: 412-692-4821
Fax: 412-692-4825
E-mail: liebschutzjm@upmc.edu
Administrative Assistant:
Kathy Nosko
Email: noskoka@upmc.edu
Phone: 412-692-4821
Education and Training
Education
BA, Yale University, East Asian Studies (China), 1983
MD, Harvard Medical School, 1991
MPH, Boston University School of Public Health, Epidemiology and Biostatistics, 1998
Training
Residency Program in Internal Medicine, Boston City Hospital, 1994
Preventive Medicine Residency, Boston University Medical Center, 1998
General Medicine Fellowship Program, Boston University Medical Center, 1998
Faculty Fellow, Prevention and Other Drug Abuse Faculty Development Program, Boston University Medical Center, 2001
Research Interest
Dr. Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly her research focuses on substance use, violence, and mental health within the practice of general medical care. Earlier in her career, she studied violence and its health impacts—knowledge that she uses in her current work on substance abuse disorders. Dr. Liebschutz has conducted numerous observation and intervention studies, including research on opioid prescribing for chronic pain in primary care. She has also directed randomized trials to study the treatment of opioid and injection drug use disorders in hospitalized patients. Dr. Liebschutz has a sustained history of funding, including current R01 funding to study “Implementing opioid risk reduction strategies into primary care practice.”

Her research has been supported by the NIH’s National Institute on Drug Abuse, Health Resources and Services Administration, the Robert Wood Johnson Foundation, the American Cancer Society, the Substance Abuse and Mental Health Services Administration, and the Agency for Healthcare Quality and Research. She has been a frequent speaker at national and international conferences held by, among others, the Society of General Internal Medicine, the American College of Physicians, the College on Problems of Drug Dependency, and the National Drug Abuse Treatment Clinical Trials Network. Her topics have ranged from intimate partner violence and chronic pain management to work-life integration.
Clinical Interest
Dr. Liebschutz is a primary care doctor who also practices addiction medicine, having cared for hundreds of patients with substance use disorder. Her clinical practice has focused on underserved populations. She is particularly interested in caring for patients who have experienced the triad of trauma, pain and substance use. She also enjoys employing her Spanish language skills with immigrants from Spanish speaking countries.
Educational Interest
Dr. Liebschutz previously served as PI on multiple training awards, including a T32 training award for post-doctoral training of primary care physicians, and has an impressive track record of mentoring undergraduates, medical students, residents, fellows, many of whom have received faculty appointments at Boston University School of Medicine and at other academic medical centers across the nation.

Dr. Liebschutz also has a strong interest in faculty development and physician workforce diversity. She has led programs in faculty development and physician resilience. She is dedicated to promoting, mentoring and supporting under-represented minority trainees and faculty.

Lastly, she is a strong supporting of physician wellness, having directed a wellness initiative for 5 years. She has also conducted data collection and research in the field of burn-out and wellness. She hopes to continue to develop the data to support interventions to decrease burnout and improve vitality among primary care physicians and academic medical faculty.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Liebschutz J, Saitz R, Brower V, Keane TM, Lloyd-Travaglini C, Averbuch T, Samet JH. PTSD in Urban Primary Care: High Prevalence and Low Physician Recognition. Journal of General Internal Medicine. 2007; 22(6): 719-726.
Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis LE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. Journal of the National Medical Association. 2008; 100(2): 237-245.
Meltzer EC, Rybin D, Saitz R, Samet JH, Schwartz SL, Butler SF, Liebschutz JM. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011; 152(2): 397-402.
Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz SL, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. Journal of Pain. 2010; 11(11): 1047-1055.
Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, Stein M. Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial. JAMA Internal Medicine. 2014; 174(8): 1369-1376.
Liebschutz J, Battaglia T, Finley E, Averbuch T. Disclosing intimate partner violence to health care clinicians - what a difference the setting makes: a qualitative study. BMC Public Health. 2008; 8: 229.
Kartha A, Brower V, Saitz R, Samet JH, Keane TM, Liebschutz J. The impact of trauma exposure and post-traumatic stress disorder on healthcare utilization among primary care patients. Medical Care. 2008; 46(4): 388-393.
Fogarty CT, Fredman L, Heeren TC, Liebschutz J. Synergistic effects of child abuse and intimate partner violence on depressive symptoms in women. Preventive Medicine. 2008; 46(5): 463-469.
LaRochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study. Annals of Internal Medicine. 2016; 164(1): 1-9.
Paranjape A, Rask K, Liebschutz J. Utility of STaT for the identification of recent intimate partner violence. Journal of the National Medical Association. 2006; 98(10): 1663-1669.
Sponsored Research/Activities
Title: Developing an intervention to address opioid stigma in cancer survivors: formative work
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: UG1 DA049436
Start Year: 2020
End Year: 2021
Title: Appalachian Node
Role: Principal Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: UG1
Start Year: 2019
End Year: 2024
Title: NorthStar Node of the Clinical Trials Network
Role: Principal Investigator
Funding Agency: Hennepin County Medical Center/ National Agency for Drug Abuse
Grant Number: R01 DA040316
Start Year: 2019
End Year: 2019
Title: PDM System User Training
Role: Principal Investigator
Funding Agency: Commonwealth of Pennsylvania/ Center for Disease Control
Start Year: 2019
End Year: 2019
Title: Subthreshold Opioid Use Disorder Prevention (STOP) Trial
Role: Principal Investigator
Funding Agency: McClean Hospital/ National Institute of Health
Grant Number: UG1 UG1DA015831
Start Year: 2019
End Year: 2019
Title: University of Pittsburgh Collaboration in Addiction Training Scholars (PittCATS) Program
Role: Co-Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: K12 DA050607
Start Year: 2020
End Year: 2025
Title: Consensus-based algorithms to address opioid misuse behaviors among individuals prescribed long-term opioid therapy: developing implementation strategies and pilot testing
Role: Co-Investigator
Funding Agency: National Agency for Drug Abuse
Grant Number: R34 DA050004
Start Year: 2020
End Year: 2023
Title: CDC PDMP OD2A Predictive Analytics Project
Role: Co-Investigator
Funding Agency: PA Department of Health / Center for Disease Control
Grant Number: RES
Start Year: 2020
End Year: 2022
Title: Implementing Prediction Models to Improve Opioid Risk
Role: Co-Investigator
Funding Agency: Richard King Mellon Foundation
Grant Number: RES 9909
Start Year: 2020
End Year: 2022
Title: Evaluation of the Efficacy and Mechanism of a Novel Intervention for Chronic Pain Tailored to People Living with HIV
Role: Co-Investigator
Funding Agency: National Institute of Mental Health
Grant Number: R01 MH115754
Start Year: 2018
End Year: 2023
Notable Achievements
Best Abstract Award, Association of Medical Education and Research in Substance Abuse, 2017
Thomas A. Pitts Lectureship in Medical Ethics, Charleston, SC, 2014
Philip Bernstein Society Annual Speaker, Temple B’rith Kodesh, Rochester, NY, 2012
Best Doctors in America, 2010–2015
Community Clinician of the Year, Suffolk District Medical Society, 2012
“Best of Boston” Top 100 Doctors, 2007
Fellow, American College of Physicians, 2003
Women and Gender Travel Award, College on Problems of Drug Dependency, 2000
Best Abstract Award, Annual Meeting of Association of Medical Education and Research in Substance Abuse, 1995